Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 Trial.

Minneboo M, Lachman S, Snaterse M, Jørstad HT, Ter Riet G, Boekholdt SM, Scholte Op Reimer WJM, Peters RJG; RESPONSE-2 Study Group.

J Am Coll Cardiol. 2017 Jul 18;70(3):318-327. doi: 10.1016/j.jacc.2017.05.041.

PMID:
28705312
2.

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators.

Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x.

PMID:
21679231
3.

n-3 fatty acids and cardiovascular events after myocardial infarction.

Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group.

N Engl J Med. 2010 Nov 18;363(21):2015-26. doi: 10.1056/NEJMoa1003603. Epub 2010 Aug 28.

4.

Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial.

Geleijnse JM, Giltay EJ, Schouten EG, de Goede J, Oude Griep LM, Teitsma-Jansen AM, Katan MB, Kromhout D; Alpha Omega Trial Group.

Am Heart J. 2010 Apr;159(4):539-546.e2. doi: 10.1016/j.ahj.2009.12.033.

PMID:
20362710
5.

Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty.

Voskuil M, van Liebergen RA, Albertal M, Boersma E, Tijssen JG, Serruys PW, Piek JJ; DEBATE II Investigators.

J Am Coll Cardiol. 2002 May 1;39(9):1513-7.

6.

Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease.

Chamuleau SA, Tio RA, de Cock CC, de Muinck ED, Pijls NH, van Eck-Smit BL, Koch KT, Meuwissen M, Dijkgraaf MG, de Jong A, Verberne HJ, van Liebergen RA, Laarman GJ, Tijssen JG, Piek JJ.

J Am Coll Cardiol. 2002 Mar 6;39(5):852-8.

7.

Early lumen diameter loss after percutaneous transluminal coronary angioplasty is related to coronary plaque burden: a role for viscous plaque properties in early lumen diameter loss.

Kok WE, Peters RJ, Pasterkamp G, van Liebergen RA, Piek JJ, Koch KT, Visser CA.

Int J Cardiovasc Imaging. 2001 Apr;17(2):111-21.

PMID:
11558970
8.

Hyperemic coronary flow after optimized intravascular ultrasound-guided balloon angioplasty and stent implantation.

van Liebergen RA, Piek JJ, Koch KT, Peters RJ, de Winter RJ, Schotborgh CE, Lie KI.

J Am Coll Cardiol. 1999 Dec;34(7):1899-906.

9.
10.

Quantification of collateral flow in humans: a comparison of angiographic, electrocardiographic and hemodynamic variables.

van Liebergen RA, Piek JJ, Koch KT, de Winter RJ, Schotborgh CE, Lie KI.

J Am Coll Cardiol. 1999 Mar;33(3):670-7.

11.
14.

Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion.

Piek JJ, van Liebergen RA, Koch KT, Peters RJ, David GK.

J Am Coll Cardiol. 1997 Feb;29(2):275-82.

Supplemental Content

Loading ...
Support Center